Deutsche Bank
CAPR icon

Deutsche Bank’s Capricor Therapeutics CAPR Stock Holding History

Deutsche Bank’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
57,579
+18,994
+49% +$576K ﹤0.01% 2130
2026
Q1 		$1.17M Buy
38,585
+9,853
+34% +$263K ﹤0.01% 2092
2025
Q4 		$829K Buy
28,732
+3,643
+15% +$47.6K ﹤0.01% 2288
2025
Q3 		$181K Sell
25,089
-2,678
-10% -$19.7K ﹤0.01% 3113
2025
Q2 		$276K Sell
27,767
-932
-3% -$9.85K ﹤0.01% 2780
2025
Q1 		$272K Buy
28,699
+2,822
+11% +$39.2K ﹤0.01% 2802
2024
Q4 		$357K Buy
+25,877
New +$453K ﹤0.01% 2795
2021
Q3 		– Sell
-145
Closed -$1K – 4425
2021
Q2 		$1K Buy
+145
New +$614 ﹤0.01% 4553
2020
Q1 		– Sell
-2,170
Closed -$2K – 4376
2019
Q4 		$2K Buy
+2,170
New +$4.48K ﹤0.01% 4812
2018
Q2 		– Sell
-60
Closed – – 5419
2018
Q1 		$0 Sell
60
-240
-80% -$4.16K ﹤0.01% 5406
2017
Q4 		$4K Buy
300
+180
+150% +$3.9K ﹤0.01% 4872
2017
Q3 		$3K Buy
+120
New +$1.44K ﹤0.01% 4774

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deutsche Bank's CAPR Position: Q2 2026 in Review

Deutsche Bank increased its Capricor Therapeutics (CAPR) stake by 49% in Q2 2026, buying an estimated $576K and bringing the position to 57,579 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Deutsche Bank first reported a position in CAPR in Q3 2017 and has held it in 12 quarters since. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Deutsche Bank held 57,579 shares of Capricor Therapeutics worth $1.39M as of Q2 2026.
  • Deutsche Bank bought 18,994 Capricor Therapeutics shares in Q2 2026, an estimated $576K.
  • Capricor Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2130 holding.
  • Deutsche Bank first reported a position in Capricor Therapeutics in Q3 2017 and has held it in 12 quarters since.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.